Isomer-specific antidiabetic properties of conjugated linoleic acid: Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression

J. W. Ryder, C. P. Portocarrero, X. M. Song, L. Cui, M. Yu, T. Combatsiaris, D. Galuska, D. E. Bauman, D. M. Barbano, Maureen J. Charron, J. R. Zierath, K. L. Houseknecht

Research output: Contribution to journalArticle

262 Citations (Scopus)

Abstract

Conjugated linoleic acid (CLA) isomers have a number of beneficial health effects, as shown in biomedical studies with animal models. Previously, we reported that a mixture of CLA isomers improved glucose tolerance in ZDF rats and activated peroxisome proliferator-activated receptor (PPAR)-γ response elements in vitro. Here, our aim was to elucidate the effect(s) of specific CLA isomers on whole-body glucose tolerance, insulin action in skeletal muscle, and expression of genes important in glucose and lipid metabolism. ZDF rats were fed either a control diet (CON), one of two CLA supplemented diets (1.5% CLA) containing differing isoforms of CLA (47% c9,t11; 47.9% c10,t12, 50:50; or 91% c9,t11, c9,t11 isomers), or were pair-fed CON diet to match the intake of 50:50. The 50:50 diet reduced adiposity and improved glucose tolerance compared with all other ZDF treatments. Insulin-stimulated glucose transport and glycogen synthase activity in skeletal muscle were improved with 50:50 compared with all other treatments. Neither phosphatidlyinositol 3-kinase activity nor Akt activity in muscle was affected by treatment. Uncoupling protein 2 in muscle and adipose tissue was upregulated by c9,t11 and 50:50 compared with ZDF controls. PPAR-γ mRNA was downregulated in liver of c9,t11 and pair-fed ZDF rats. Thus, the improved glucose tolerance in 50:50 rats is attributable to, at least in part, improved insulin action in muscle, and CLA effects cannot be explained simply by reduced food intake.

Original languageEnglish (US)
Pages (from-to)1149-1157
Number of pages9
JournalDiabetes
Volume50
Issue number5
StatePublished - 2001

Fingerprint

Conjugated Linoleic Acids
Hypoglycemic Agents
Skeletal Muscle
Insulin
Gene Expression
Glucose
Diet
Peroxisome Proliferator-Activated Receptors
Muscles
Glycogen Synthase
Adiposity
Response Elements
Lipid Metabolism
Adipose Tissue
Protein Isoforms
Phosphotransferases
Down-Regulation
Animal Models
Eating
Messenger RNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Ryder, J. W., Portocarrero, C. P., Song, X. M., Cui, L., Yu, M., Combatsiaris, T., ... Houseknecht, K. L. (2001). Isomer-specific antidiabetic properties of conjugated linoleic acid: Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes, 50(5), 1149-1157.

Isomer-specific antidiabetic properties of conjugated linoleic acid : Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. / Ryder, J. W.; Portocarrero, C. P.; Song, X. M.; Cui, L.; Yu, M.; Combatsiaris, T.; Galuska, D.; Bauman, D. E.; Barbano, D. M.; Charron, Maureen J.; Zierath, J. R.; Houseknecht, K. L.

In: Diabetes, Vol. 50, No. 5, 2001, p. 1149-1157.

Research output: Contribution to journalArticle

Ryder, JW, Portocarrero, CP, Song, XM, Cui, L, Yu, M, Combatsiaris, T, Galuska, D, Bauman, DE, Barbano, DM, Charron, MJ, Zierath, JR & Houseknecht, KL 2001, 'Isomer-specific antidiabetic properties of conjugated linoleic acid: Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression', Diabetes, vol. 50, no. 5, pp. 1149-1157.
Ryder, J. W. ; Portocarrero, C. P. ; Song, X. M. ; Cui, L. ; Yu, M. ; Combatsiaris, T. ; Galuska, D. ; Bauman, D. E. ; Barbano, D. M. ; Charron, Maureen J. ; Zierath, J. R. ; Houseknecht, K. L. / Isomer-specific antidiabetic properties of conjugated linoleic acid : Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. In: Diabetes. 2001 ; Vol. 50, No. 5. pp. 1149-1157.
@article{44ec53d9fd0c4ec28281bed3622c82a9,
title = "Isomer-specific antidiabetic properties of conjugated linoleic acid: Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression",
abstract = "Conjugated linoleic acid (CLA) isomers have a number of beneficial health effects, as shown in biomedical studies with animal models. Previously, we reported that a mixture of CLA isomers improved glucose tolerance in ZDF rats and activated peroxisome proliferator-activated receptor (PPAR)-γ response elements in vitro. Here, our aim was to elucidate the effect(s) of specific CLA isomers on whole-body glucose tolerance, insulin action in skeletal muscle, and expression of genes important in glucose and lipid metabolism. ZDF rats were fed either a control diet (CON), one of two CLA supplemented diets (1.5{\%} CLA) containing differing isoforms of CLA (47{\%} c9,t11; 47.9{\%} c10,t12, 50:50; or 91{\%} c9,t11, c9,t11 isomers), or were pair-fed CON diet to match the intake of 50:50. The 50:50 diet reduced adiposity and improved glucose tolerance compared with all other ZDF treatments. Insulin-stimulated glucose transport and glycogen synthase activity in skeletal muscle were improved with 50:50 compared with all other treatments. Neither phosphatidlyinositol 3-kinase activity nor Akt activity in muscle was affected by treatment. Uncoupling protein 2 in muscle and adipose tissue was upregulated by c9,t11 and 50:50 compared with ZDF controls. PPAR-γ mRNA was downregulated in liver of c9,t11 and pair-fed ZDF rats. Thus, the improved glucose tolerance in 50:50 rats is attributable to, at least in part, improved insulin action in muscle, and CLA effects cannot be explained simply by reduced food intake.",
author = "Ryder, {J. W.} and Portocarrero, {C. P.} and Song, {X. M.} and L. Cui and M. Yu and T. Combatsiaris and D. Galuska and Bauman, {D. E.} and Barbano, {D. M.} and Charron, {Maureen J.} and Zierath, {J. R.} and Houseknecht, {K. L.}",
year = "2001",
language = "English (US)",
volume = "50",
pages = "1149--1157",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Isomer-specific antidiabetic properties of conjugated linoleic acid

T2 - Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression

AU - Ryder, J. W.

AU - Portocarrero, C. P.

AU - Song, X. M.

AU - Cui, L.

AU - Yu, M.

AU - Combatsiaris, T.

AU - Galuska, D.

AU - Bauman, D. E.

AU - Barbano, D. M.

AU - Charron, Maureen J.

AU - Zierath, J. R.

AU - Houseknecht, K. L.

PY - 2001

Y1 - 2001

N2 - Conjugated linoleic acid (CLA) isomers have a number of beneficial health effects, as shown in biomedical studies with animal models. Previously, we reported that a mixture of CLA isomers improved glucose tolerance in ZDF rats and activated peroxisome proliferator-activated receptor (PPAR)-γ response elements in vitro. Here, our aim was to elucidate the effect(s) of specific CLA isomers on whole-body glucose tolerance, insulin action in skeletal muscle, and expression of genes important in glucose and lipid metabolism. ZDF rats were fed either a control diet (CON), one of two CLA supplemented diets (1.5% CLA) containing differing isoforms of CLA (47% c9,t11; 47.9% c10,t12, 50:50; or 91% c9,t11, c9,t11 isomers), or were pair-fed CON diet to match the intake of 50:50. The 50:50 diet reduced adiposity and improved glucose tolerance compared with all other ZDF treatments. Insulin-stimulated glucose transport and glycogen synthase activity in skeletal muscle were improved with 50:50 compared with all other treatments. Neither phosphatidlyinositol 3-kinase activity nor Akt activity in muscle was affected by treatment. Uncoupling protein 2 in muscle and adipose tissue was upregulated by c9,t11 and 50:50 compared with ZDF controls. PPAR-γ mRNA was downregulated in liver of c9,t11 and pair-fed ZDF rats. Thus, the improved glucose tolerance in 50:50 rats is attributable to, at least in part, improved insulin action in muscle, and CLA effects cannot be explained simply by reduced food intake.

AB - Conjugated linoleic acid (CLA) isomers have a number of beneficial health effects, as shown in biomedical studies with animal models. Previously, we reported that a mixture of CLA isomers improved glucose tolerance in ZDF rats and activated peroxisome proliferator-activated receptor (PPAR)-γ response elements in vitro. Here, our aim was to elucidate the effect(s) of specific CLA isomers on whole-body glucose tolerance, insulin action in skeletal muscle, and expression of genes important in glucose and lipid metabolism. ZDF rats were fed either a control diet (CON), one of two CLA supplemented diets (1.5% CLA) containing differing isoforms of CLA (47% c9,t11; 47.9% c10,t12, 50:50; or 91% c9,t11, c9,t11 isomers), or were pair-fed CON diet to match the intake of 50:50. The 50:50 diet reduced adiposity and improved glucose tolerance compared with all other ZDF treatments. Insulin-stimulated glucose transport and glycogen synthase activity in skeletal muscle were improved with 50:50 compared with all other treatments. Neither phosphatidlyinositol 3-kinase activity nor Akt activity in muscle was affected by treatment. Uncoupling protein 2 in muscle and adipose tissue was upregulated by c9,t11 and 50:50 compared with ZDF controls. PPAR-γ mRNA was downregulated in liver of c9,t11 and pair-fed ZDF rats. Thus, the improved glucose tolerance in 50:50 rats is attributable to, at least in part, improved insulin action in muscle, and CLA effects cannot be explained simply by reduced food intake.

UR - http://www.scopus.com/inward/record.url?scp=0035041793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035041793&partnerID=8YFLogxK

M3 - Article

C2 - 11334420

AN - SCOPUS:0035041793

VL - 50

SP - 1149

EP - 1157

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -